Fusion Antibodies plc

Company Profile

Company website
Health Care Providers (Health Care Services)

Fusion Antibodies plc (AIM: FAB) is a contract research organisation providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications.   

Investor Access

05 Dec
Event information

Management will announce its unaudited interim results for the six months ended 30 September 2022 on Monday 5th December 2022.

Management will hold a presentation for Investors through the digital platform, Investor Meet Company, on Friday 9th December 2022 at 10:00 relating to its interim results for the six months ended 30 September 2022.  Investors can sign up to Investor Meet Company for free, by clicking: https://www.investormeetcompany.com/fusion-antibodies-plc/register-investor


Monday 5th December 2022

Financial Calendar
 Event  Date
Year End 31 March
Half  Year End 30 September
Preliminary Results* August
Interim Results* November
AGM* September

* Months based on previous announcements of this kind